Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Total Debt (2016 - 2023)

Historic Total Debt for Arcadia Biosciences (RKDA) over the last 10 years, with Q1 2023 value amounting to $15000.0.

  • Arcadia Biosciences' Total Debt fell 7826.09% to $15000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $15000.0, marking a year-over-year decrease of 7826.09%. This contributed to the annual value of $48000.0 for FY2022, which is 2500.0% down from last year.
  • According to the latest figures from Q1 2023, Arcadia Biosciences' Total Debt is $15000.0, which was down 7826.09% from $48000.0 recorded in Q4 2022.
  • Arcadia Biosciences' Total Debt's 5-year high stood at $3.3 million during Q2 2020, with a 5-year trough of $12000.0 in Q1 2019.
  • For the 5-year period, Arcadia Biosciences' Total Debt averaged around $773176.5, with its median value being $129000.0 (2021).
  • Its Total Debt has fluctuated over the past 5 years, first surged by 1706315.79% in 2020, then crashed by 9802.83% in 2021.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Total Debt stood at $147000.0 in 2019, then skyrocketed by 2108.16% to $3.2 million in 2020, then plummeted by 98.03% to $64000.0 in 2021, then dropped by 25.0% to $48000.0 in 2022, then plummeted by 68.75% to $15000.0 in 2023.
  • Its Total Debt stands at $15000.0 for Q1 2023, versus $48000.0 for Q4 2022 and $47000.0 for Q3 2022.